Macrophage Pharma has appointed Dr Michael Moore as chairman. Michael is currently a non-executive director of several private and public bioscience companies, including Mission Therapeutics, NASDAQ-listed Trillium Therapeutics and Mironid. He is also currently chairman of Chronos Therapeutics and was founder chairman of PsiOxus Therapeutics and was previously CEO of Piramed.